Skip to main content
N

NOXOPHARM LIMITED — Investor Relations & Filings

Ticker · NOX ISIN · AU000000NOX9 ASX Professional, scientific and technical activities
Filings indexed 62 across all filing types
Latest filing 2026-01-01 Regulatory Filings
Country AU Australia
Listing ASX NOX

About NOXOPHARM LIMITED

https://www.noxopharm.com

Noxopharm Limited is a clinical-stage drug development company focused on the discovery and development of novel treatments for cancer and inflammation. The company utilizes its proprietary drug discovery platforms, including Chroma and Sofra, to create a pipeline of therapeutic candidates. Its lead oncology asset, Veyonda, is designed to function as a radio-enhancer and chemo-sensitizer, aiming to improve the efficacy of existing cancer treatments. Additionally, the Sofra platform focuses on the development of synthetic oligonucleotides to modulate the immune system, specifically targeting toll-like receptors 7 and 8 to treat autoimmune and inflammatory diseases. Noxopharm also explores applications in mRNA vaccine technology through its SOF-VAC program, which aims to reduce the inflammatory side effects associated with mRNA-based therapeutics.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - NOX 7 pages 21.0KB
Regulatory Filings
2026-01-01 English
Notice under s708A(12C)(e) of the Corporations Act 2001 13 pages 638.9KB
Regulatory Filings
2026-01-01 English
Notification regarding unquoted securities - NOX 7 pages 20.9KB
Regulatory Filings
2025-12-11 English
Notice under s708A(12C)(e) of the Corporations Act 2001 11 pages 632.7KB
Regulatory Filings
2025-12-11 English
Change of Director's Interest Notice - FB 2 pages 5.9KB
Regulatory Filings
2025-12-11 English
HERACLES clinical trial Update 5 3 pages 297.1KB
Regulatory Filings
2025-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.